Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute changes in serum thyrotrophin in treated Addison's disease.

A A Ismail1, W A Burr, P L Walker

  • 1Department of Clinical Biochemistry, Pinderfields General Hospital, Wakefield, West Yorkshire, UK.

Clinical Endocrinology
|March 1, 1989
PubMed
Summary

Morning steroid replacement therapy in Addison's disease patients significantly lowers Thyroid-Stimulating Hormone (TSH) levels. This effect highlights the importance of timing blood draws relative to medication for accurate TSH interpretation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the impact of housing modifications on milk infrared spectra as indicators of dairy cow welfare status.

Scientific reports·2025
Same author

Maggot debridement therapy to treat hard-to-heal diabetic foot ulcers: a single-centre study.

Journal of wound care·2021
Same author

Group A Streptococcus puerperal sepsis with invasive neonatal infection: A fatal case.

The Medical journal of Malaysia·2021
Same author

Zika virus modulates blood-brain barrier of brain microvascular endothelial cells.

Tropical biomedicine·2021
Same author

First report and molecular characterization of <i>Cryptosporidium</i> spp. in humans and animals in Khartoum state, Sudan.

Veterinary world·2019
Same author

Chronic magnesium deficiency and human disease; time for reappraisal?

QJM : monthly journal of the Association of Physicians·2017

Area of Science:

  • Endocrinology
  • Hormone Replacement Therapy
  • Thyroid Function Testing

Background:

  • Addison's disease requires lifelong glucocorticoid and often mineralocorticoid replacement therapy.
  • Thyroid-stimulating hormone (TSH) levels are a key indicator of thyroid function and can be influenced by various factors.
  • The impact of acute steroid administration on TSH levels in Addison's disease patients is not well-established.

Purpose of the Study:

  • To investigate the acute effect of morning steroid replacement therapy on serum TSH levels in patients with Addison's disease.
  • To assess the influence of hydrocortisone and dexamethasone on TSH, ACTH, and other pituitary hormone levels.
  • To determine the impact of medication timing on TSH measurement accuracy in treated Addison's disease.

Main Methods:

Related Experiment Videos

  • Measurement of serum cortisol, plasma ACTH, serum TSH, free T4, free T3, PRL, LH, and FSH.
  • Serial blood sampling hourly for 4 hours post-morning steroid (hydrocortisone) administration.
  • Comparison with measurements obtained when morning steroid dose was withheld and after dexamethasone administration in some patients.

Main Results:

  • Serum TSH levels significantly decreased in all five patients within 4 hours after hydrocortisone administration.
  • This TSH reduction was not observed when the morning steroid dose was withheld.
  • Dexamethasone also induced similar TSH changes in two patients; LH, FSH, and PRL levels showed no consistent changes.

Conclusions:

  • Acute administration of hydrocortisone, a common steroid replacement therapy, transiently suppresses TSH levels in Addison's disease patients.
  • The timing of blood sample collection relative to steroid medication intake is crucial for accurate TSH interpretation in this population.
  • Clinicians should consider the influence of recent steroid therapy when evaluating TSH results in patients with treated Addison's disease.